Skip to Main Navigation

Implementation Completion and Results Report (ICR) Document - Support to Research and Development at the International AIDS Vaccine Initiative - P161232 (English)

Ratings of the Support to Research and Development at the International Acquired Immune Deficiency Syndrome (AIDS) Vaccine Initiative Project were as follows: outcome was highly satisfactory, Bank performance was highly satisfactory, and monitoring and evaluation quality was substantial. Some of the lessons learned include: (i) Over at least the last fifteen years, supporting country capacity to prevent, detect, monitor and respond to infectious diseases has been a consistent policy priority; (ii) The International AIDS Vaccine Initiative (IAVI) support has been almost unique in the Bank’s portfolio, in that it has directly supported the most basic, science driven research and development; (iii) In the second year of this project, it was recognized that based on its successful track record in developing an Human Immunodeficiency Virus (HIV) vaccine, IAVI had a critical role to play in coordinating international partners around vaccine development for other infectious diseases; (iv) Both the financial support and the regular oversight provided by the World Bank have helped advance this vaccine

Details

  • Author

    Oelrichs,Robert

  • Document Date

    2019/04/12

  • Document Type

    Implementation Completion and Results Report

  • Report Number

    ICR00004605

  • Volume No

    1

  • Total Volume(s)

    1

  • Country

    World,

  • Region

    Other, The World Region,

  • Disclosure Date

    2019/04/12

  • Disclosure Status

    Disclosed

  • Doc Name

    Implementation Completion and Results Report (ICR) Document - Support to Research and Development at the International AIDS Vaccine Initiative - P161232

  • Keywords

    Environmental Management Plan; monitoring and evaluation design; Acquired Immune Deficiency Syndrome; research and development funding; Occupational health and safety; monitoring and evaluation data; global public good; emerging infectious disease; source of funding; net present value; subject matter expert; vaccine development; production of vaccine; incidence of disease; financial management capability; standard operating procedure; multiple funding sources; dissemination of knowledge; people with hiv; subjectmatter expertise; quality of supervision; quality at entry; impact on poverty; management of risk; fiduciary risk management; internal audit function; private sector financing; private sector engagement; disease of poverty; future cash flow; infectious disease threat; private sector resource; discounted cash flow; vaccine candidate; immune response; global health; viral vector; recombinant vaccine; virus particle; results framework; vaccine trial; outcome indicator; procurement activities; aids vaccine; clinical trial; basic science; public health; virus characteristics; antibody response; treatment programs; intermediate outcome; research outcome; international collaboration; candidate vaccine; genetic stability

Downloads

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Citation

Oelrichs,Robert

Implementation Completion and Results Report (ICR) Document - Support to Research and Development at the International AIDS Vaccine Initiative - P161232 (English). Washington, D.C. : World Bank Group. http://documents.worldbank.org/curated/en/262661555033311333/Implementation-Completion-and-Results-Report-ICR-Document-Support-to-Research-and-Development-at-the-International-AIDS-Vaccine-Initiative-P161232